Increased Neonatal Respiratory Morbidity Associated with Gestational and Pregestational Diabetes: A Retrospective Study

 

 Buy Article Permissions and Reprints

Abstract

Objective To examine the risk of neonatal respiratory morbidity associated with gestational and pregestational diabetes, accounting for the prematurity-associated risk using a propensity score analysis.

Study design In a retrospective study including 222,978 singleton pregnancies, delivering at 24^0/7 to 41^6/7 weeks (2002–2008), we calculated a probability to deliver at term (≥37 weeks of gestation). Outcomes were stratified by the probability to deliver at term (>0.8 and ≤0.8). Adjusted odds ratios (aORs) with 95% confidence intervals (95% CIs) were calculated.

Results Gestational and pregestational diabetes complicated 5.1 and 1.5% of pregnancies, respectively, and were associated with increased risks of neonatal respiratory morbidity compared with women without diabetes regardless of probability to deliver at term. However, these risks tended to be higher with a higher probability to deliver at term: respiratory distress syndrome (aOR: 1.5; 95% CI: 1.3–1.7 and aOR: 3.1; 95% CI: 2.6–3.7); transient tachypnea of newborn (aOR: 1.5; 95% CI: 1.3–1.6 and aOR: 2.2; 95% CI: 1.9–2.6); and apnea (aOR: 1.5; 95% CI: 1.2–1.7 and aOR: 3.2; 95% CI: 2.6–3.9, for gestational and pregestational at term, respectively).

Conclusion Diabetes was associated with increased risk of neonatal respiratory morbidity beyond what can be attributed to prematurity. Neonatal respiratory morbidities were increased with pregestational diabetes compared with gestational diabetes.

Note

This article was presented as an oral presentation at the SMFM 32th Annual Meeting—The Pregnancy Meeting, Dallas, TX (February 6–11, 2012).

• References

• 1 DeSisto CL, Kim SY, Sharma AJ. Prevalence estimates of gestational diabetes mellitus in the United States, Pregnancy Risk Assessment Monitoring System (PRAMS), 2007-2010. Prev Chronic Dis 2014; 11: E104
  PubMedGoogle Scholar
• 2 Wier LM, Witt E, Burgess J, Elixhauser A. Hospitalizations Related to Diabetes in Pregnancy, 2008. HCUP Statistical Brief #102. Rockville, MD: Agency for Healthcare Research and Quality; 2010
  Google Scholar
• 3 Hedderson MM, Darbinian JA, Ferrara A. Disparities in the risk of gestational diabetes by race-ethnicity and country of birth. Paediatr Perinat Epidemiol 2010; 24 (05) 441-448
  CrossrefPubMedGoogle Scholar
• 4 Bental Y, Reichman B, Shiff Y. , et al; Collaboration With the Israel Neonatal Network. Impact of maternal diabetes mellitus on mortality and morbidity of preterm infants (24-33 weeks' gestation). Pediatrics 2011; 128 (04) e848-e855
  CrossrefPubMedGoogle Scholar
• 5 El Mallah KO, Narchi H, Kulaylat NA, Shaban MS. Gestational and pre-gestational diabetes: comparison of maternal and fetal characteristics and outcome. Int J Gynaecol Obstet 1997; 58 (02) 203-209
  CrossrefPubMedGoogle Scholar
• 6 Becquet O, El Khabbaz F, Alberti C. , et al. Insulin treatment of maternal diabetes mellitus and respiratory outcome in late-preterm and term singletons. BMJ Open 2015; 5 (06) e008192
  CrossrefPubMedGoogle Scholar
• 7 Mimouni F, Miodovnik M, Whitsett JA, Holroyde JC, Siddiqi TA, Tsang RC. Respiratory distress syndrome in infants of diabetic mothers in the 1980s: no direct adverse effect of maternal diabetes with modern management. Obstet Gynecol 1987; 69 (02) 191-195
  PubMedGoogle Scholar
• 8 McMahan MJ, Mimouni F, Miodovnik M, Hull WM, Whitsett JA. Surfactant associated protein (SAP-35) in amniotic fluid from diabetic and nondiabetic pregnancies. Obstet Gynecol 1987; 70 (01) 94-98
  PubMedGoogle Scholar
• 9 McGillick EV, Morrison JL, McMillen IC, Orgeig S. Intrafetal glucose infusion alters glucocorticoid signaling and reduces surfactant protein mRNA expression in the lung of the late-gestation sheep fetus. Am J Physiol Regul Integr Comp Physiol 2014; 307 (05) R538-R545
  CrossrefPubMedGoogle Scholar
• 10 Sibai BM, Caritis S, Hauth J. , et al; National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Risks of preeclampsia and adverse neonatal outcomes among women with pregestational diabetes mellitus. Am J Obstet Gynecol 2000; 182 (02) 364-369
  CrossrefPubMedGoogle Scholar
• 11 Robert MF, Neff RK, Hubbell JP, Taeusch HW, Avery ME. Association between maternal diabetes and the respiratory-distress syndrome in the newborn. N Engl J Med 1976; 294 (07) 357-360
  CrossrefPubMedGoogle Scholar
• 12 Hibbard JU, Wilkins I, Sun L. , et al; Consortium on Safe Labor. Respiratory morbidity in late preterm births. JAMA 2010; 304 (04) 419-425
  CrossrefPubMedGoogle Scholar
• 13 Akhlaghi F, Hamedi AB. Comparison of maternal and fetal/neonatal complications in gestational and pre-gestational diabetes mellitus. Acta Med Iran 2005; 43 (04) 263-267
  PubMedGoogle Scholar
• 14 Neelakandan R, Sethu PS. Early universal screening for gestational diabetes mellitus. J Clin Diagn Res 2014; 8 (04) OC12-OC14
  PubMedGoogle Scholar
• 15 Zhang J, Troendle J, Reddy UM. , et al; Consortium on Safe Labor. Contemporary cesarean delivery practice in the United States. Am J Obstet Gynecol 2010; 203 (04) 326.e1-326.e10
  CrossrefPubMedGoogle Scholar
• 16 Wilcox AJ, Weinberg CR, Basso O. On the pitfalls of adjusting for gestational age at birth. Am J Epidemiol 2011; 174 (09) 1062-1068
  CrossrefPubMedGoogle Scholar
• 17 Kramer MS, Zhang X, Platt RW. Analyzing risks of adverse pregnancy outcomes. Am J Epidemiol 2014; 179 (03) 361-367
  CrossrefPubMedGoogle Scholar
• 18 Rubin DB. On principles for modeling propensity scores in medical research. Pharmacoepidemiol Drug Saf 2004; 13 (12) 855-857
  CrossrefPubMedGoogle Scholar
• 19 Martin JA, Hamilton BE, Sutton PD. , et al. Births: final data for 2007. Natl Vital Stat Rep 2010; 58 (24) 1-85
  PubMedGoogle Scholar
• 20 Miakotina OL, Goss KL, Snyder JM. Insulin utilizes the PI 3-kinase pathway to inhibit SP-A gene expression in lung epithelial cells. Respir Res 2002; 3: 27
  CrossrefPubMedGoogle Scholar
• 21 Miakotina OL, Dekowski SA, Snyder JM. Insulin inhibits surfactant protein A and B gene expression in the H441 cell line. Biochim Biophys Acta 1998; 1442 (01) 60-70
  CrossrefPubMedGoogle Scholar
• 22 Piper JM, Xenakis EM, Langer O. Delayed appearance of pulmonary maturation markers is associated with poor glucose control in diabetic pregnancies. J Matern Fetal Med 1998; 7 (03) 148-153
  PubMedGoogle Scholar
• 23 Fong A, Serra A, Herrero T, Pan D, Ogunyemi D. Pre-gestational versus gestational diabetes: a population based study on clinical and demographic differences. J Diabetes Complications 2014; 28 (01) 29-34
  CrossrefPubMedGoogle Scholar
• 24 Committee on Practice Bulletins--Obstetrics. Practice Bulletin No. 137: Gestational diabetes mellitus. Obstet Gynecol 2013; 122 (2, Pt 1): 406-416
  CrossrefPubMedGoogle Scholar
• 25 ACOG Committee on Practice Bulletins. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60, March 2005. Pregestational diabetes mellitus. Obstet Gynecol 2005; 105 (03) 675-685
  CrossrefPubMedGoogle Scholar